Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

BACKGROUND: There is no evidence to date on immunogenic response among individuals who participated in clinical trials of COVID-19 experimental vaccines redirected to standard national vaccination regimens. METHODS: This multicentre, prospective controlled cohort study included subjects who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascaso-del-Rio, Ana, García-Pérez, Javier, Pérez-Olmeda, Mayte, Arana-Arri, Eunate, Vergara, Itziar, Pérez-Ingidua, Carla, Bermejo, Mercedes, Castillo de la Osa, María, Imaz-Ayo, Natale, Riaño Fernández, Ioana, Astasio González, Oliver, Díez-Fuertes, Francisco, Meijide, Susana, Arrizabalaga, Julio, Hernández Gutiérrez, Lourdes, de la Torre-Tarazona, Humberto Erick, Mariano Lázaro, Alberto, Vargas-Castrillón, Emilio, Alcamí, José, Portolés, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249303/
https://www.ncbi.nlm.nih.gov/pubmed/35795398
http://dx.doi.org/10.1016/j.eclinm.2022.101542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249303/
https://www.ncbi.nlm.nih.gov/pubmed/35795398
http://dx.doi.org/10.1016/j.eclinm.2022.101542

Ejemplares similares